Tryp Therapeutics Submits IND Application for Phase 2a Clinical Trial in Eating Disorders

San Diego, California–(Newsfile Corp. – September 22, 2021) – Tryp Therapeutics (CSE: TRYP) (OTCQB: TRYPF) (“Tryp“), a pharmaceutical…

Tryp Therapeutics Completes Psychotherapy Training for Phase 2a Study at the University of Florida

San Diego, California–(Newsfile Corp. – August 24, 2021) – Tryp Therapeutics (CSE: TRYP) (OTCQB: TRYPF) (“Tryp” or the…

Tryp Therapeutics Appoints Dennis Langer, M.D., J.D. as Senior Advisor

San Diego, California–(Newsfile Corp. – August 18, 2021) – Tryp Therapeutics (CSE: TRYP) (OTCQB: TRYPF) (“Tryp” or the…

Tryp Therapeutics Partners with Calvert Labs to Conduct Exploratory Studies for Proprietary Psilocybin Formulations

San Diego, California–(Newsfile Corp. – August 10, 2021) – Tryp Therapeutics (CSE: TRYP) (OTCQB: TRYPF) (“Tryp” or the…

Tryp Therapeutics Announces Q3 2021 Financial Results

San Diego, California–(Newsfile Corp. – July 28, 2021) –¬†Tryp Therapeutics¬†(CSE: TRYP) (OTCQB: TRYPF) (“Tryp” or the…

Tryp Therapeutics Appoints Robin Carhart-Harris, Ph.D. as SAB Chairman and Adds Daniel Clauw, M.D. as Scientific Advisor

San Diego, California–(Newsfile Corp. – July 26, 2021) – Tryp Therapeutics (CSE: TRYP) (OTCQB: TRYPF) (“Tryp”), a pharmaceutical…

Tryp Therapeutics Announces Plans for Phase 2a Clinical Trial for Fibromyalgia with the University of Michigan

San Diego, California–(Newsfile Corp. – July 21, 2021) – Tryp Therapeutics (CSE: TRYP) (OTCQB: TRYPF) (“Tryp”), a pharmaceutical…

Tryp Therapeutics Partners with the University of Michigan to Evaluate Proprietary Formulations

San Diego, California–(Newsfile Corp. – July 7, 2021) – Tryp Therapeutics (CSE: TRYP) (OTCQB:TRYPF) (“Tryp”), a pharmaceutical company…

Tryp Therapeutics Partners with Alcami for Proprietary Formulations

San Diego, California–(Newsfile Corp. – May 25, 2021) – Tryp Therapeutics (CSE: TRYP) (OTCQB: TRYPF) (FSE:…

Tryp Therapeutics Partners with Clinlogix for Clinical Trial Support

San Diego, California–(Newsfile Corp. – May 10, 2021) – Tryp Therapeutics (CSE: TRYP) (OTCQB: TRYPF) (FSE: 8FW) (“Tryp”),…

Tryp Therapeutics Partners with Fluence for Psychotherapy Design

San Diego, California–(Newsfile Corp. – May 3, 2021) –  Tryp Therapeutics (CSE: TRYP) (OTCQB: TRYPF) (FSE: 8FW) (“Tryp”)…

Tryp Therapeutics Announces Q2 2021 Financial Results

San Diego, California–(Newsfile Corp. – April 29, 2021) – Tryp Therapeutics Inc. (CSE: TRYP) (“Tryp” or…